nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR2B—Raloxifene—osteoporosis	0.141	0.296	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0373	0.0781	CbGbCtD
Risperidone—CYP3A7—Estradiol—osteoporosis	0.0373	0.0781	CbGbCtD
Risperidone—ABCB1—Ethinyl Estradiol—osteoporosis	0.0283	0.0592	CbGbCtD
Risperidone—CYP3A5—Estradiol—osteoporosis	0.028	0.0586	CbGbCtD
Risperidone—CYP3A4—Estropipate—osteoporosis	0.0263	0.055	CbGbCtD
Risperidone—CYP3A4—Calcitriol—osteoporosis	0.0263	0.055	CbGbCtD
Risperidone—CYP2D6—Cholecalciferol—osteoporosis	0.0213	0.0446	CbGbCtD
Risperidone—CYP3A4—Ergocalciferol—osteoporosis	0.021	0.044	CbGbCtD
Risperidone—ABCB1—Conjugated Estrogens—osteoporosis	0.0208	0.0435	CbGbCtD
Risperidone—ABCB1—Estradiol—osteoporosis	0.0182	0.0382	CbGbCtD
Risperidone—CYP3A4—Raloxifene—osteoporosis	0.0175	0.0367	CbGbCtD
Risperidone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0169	0.0355	CbGbCtD
Risperidone—CYP3A4—Cholecalciferol—osteoporosis	0.0135	0.0284	CbGbCtD
Risperidone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0124	0.026	CbGbCtD
Risperidone—CYP3A4—Estradiol—osteoporosis	0.0109	0.0229	CbGbCtD
Risperidone—Pruritus—Alendronate—osteoporosis	0.000122	0.000297	CcSEcCtD
Risperidone—Dyspepsia—Risedronate—osteoporosis	0.000122	0.000296	CcSEcCtD
Risperidone—Eye disorder—Estradiol—osteoporosis	0.000122	0.000296	CcSEcCtD
Risperidone—Tinnitus—Estradiol—osteoporosis	0.000122	0.000296	CcSEcCtD
Risperidone—Constipation—Ethinyl Estradiol—osteoporosis	0.000122	0.000295	CcSEcCtD
Risperidone—Confusional state—Zoledronate—osteoporosis	0.000122	0.000295	CcSEcCtD
Risperidone—Hypersensitivity—Calcitriol—osteoporosis	0.000122	0.000294	CcSEcCtD
Risperidone—Flushing—Estradiol—osteoporosis	0.000121	0.000294	CcSEcCtD
Risperidone—Cardiac disorder—Estradiol—osteoporosis	0.000121	0.000294	CcSEcCtD
Risperidone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000121	0.000293	CcSEcCtD
Risperidone—Myalgia—Conjugated Estrogens—osteoporosis	0.000121	0.000293	CcSEcCtD
Risperidone—Chest pain—Conjugated Estrogens—osteoporosis	0.000121	0.000293	CcSEcCtD
Risperidone—Asthenia—Ibandronate—osteoporosis	0.000121	0.000293	CcSEcCtD
Risperidone—Anxiety—Conjugated Estrogens—osteoporosis	0.000121	0.000292	CcSEcCtD
Risperidone—Nausea—Etidronic acid—osteoporosis	0.000121	0.000292	CcSEcCtD
Risperidone—Anaphylactic shock—Zoledronate—osteoporosis	0.000121	0.000292	CcSEcCtD
Risperidone—Oedema—Zoledronate—osteoporosis	0.000121	0.000292	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00012	0.000291	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00012	0.000291	CcSEcCtD
Risperidone—Diarrhoea—Estropipate—osteoporosis	0.00012	0.000291	CcSEcCtD
Risperidone—Gastrointestinal disorder—Risedronate—osteoporosis	0.00012	0.000291	CcSEcCtD
Risperidone—Infection—Zoledronate—osteoporosis	0.00012	0.00029	CcSEcCtD
Risperidone—Fatigue—Risedronate—osteoporosis	0.00012	0.00029	CcSEcCtD
Risperidone—Insomnia—Pamidronate—osteoporosis	0.000119	0.000289	CcSEcCtD
Risperidone—Pruritus—Ibandronate—osteoporosis	0.000119	0.000289	CcSEcCtD
Risperidone—Pain—Risedronate—osteoporosis	0.000119	0.000288	CcSEcCtD
Risperidone—Constipation—Risedronate—osteoporosis	0.000119	0.000288	CcSEcCtD
Risperidone—Angiopathy—Estradiol—osteoporosis	0.000119	0.000288	CcSEcCtD
Risperidone—Shock—Zoledronate—osteoporosis	0.000119	0.000287	CcSEcCtD
Risperidone—Paraesthesia—Pamidronate—osteoporosis	0.000119	0.000287	CcSEcCtD
Risperidone—Diarrhoea—Alendronate—osteoporosis	0.000118	0.000287	CcSEcCtD
Risperidone—Asthenia—Calcitriol—osteoporosis	0.000118	0.000287	CcSEcCtD
Risperidone—Nervous system disorder—Zoledronate—osteoporosis	0.000118	0.000287	CcSEcCtD
Risperidone—Immune system disorder—Estradiol—osteoporosis	0.000118	0.000286	CcSEcCtD
Risperidone—Thrombocytopenia—Zoledronate—osteoporosis	0.000118	0.000286	CcSEcCtD
Risperidone—Mediastinal disorder—Estradiol—osteoporosis	0.000118	0.000286	CcSEcCtD
Risperidone—Dyspnoea—Pamidronate—osteoporosis	0.000118	0.000285	CcSEcCtD
Risperidone—Tachycardia—Zoledronate—osteoporosis	0.000118	0.000285	CcSEcCtD
Risperidone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000117	0.000284	CcSEcCtD
Risperidone—Chills—Estradiol—osteoporosis	0.000117	0.000284	CcSEcCtD
Risperidone—Somnolence—Pamidronate—osteoporosis	0.000117	0.000284	CcSEcCtD
Risperidone—Skin disorder—Zoledronate—osteoporosis	0.000117	0.000284	CcSEcCtD
Risperidone—Pruritus—Calcitriol—osteoporosis	0.000117	0.000283	CcSEcCtD
Risperidone—Hyperhidrosis—Zoledronate—osteoporosis	0.000117	0.000282	CcSEcCtD
Risperidone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000116	0.000282	CcSEcCtD
Risperidone—Diarrhoea—Raloxifene—osteoporosis	0.000116	0.000282	CcSEcCtD
Risperidone—Dyspepsia—Pamidronate—osteoporosis	0.000116	0.000282	CcSEcCtD
Risperidone—Dizziness—Estropipate—osteoporosis	0.000116	0.000282	CcSEcCtD
Risperidone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000116	0.000281	CcSEcCtD
Risperidone—Oedema—Conjugated Estrogens—osteoporosis	0.000116	0.000281	CcSEcCtD
Risperidone—Alopecia—Estradiol—osteoporosis	0.000116	0.00028	CcSEcCtD
Risperidone—Infection—Conjugated Estrogens—osteoporosis	0.000115	0.00028	CcSEcCtD
Risperidone—Diarrhoea—Ibandronate—osteoporosis	0.000115	0.000279	CcSEcCtD
Risperidone—Anorexia—Zoledronate—osteoporosis	0.000115	0.000279	CcSEcCtD
Risperidone—Decreased appetite—Pamidronate—osteoporosis	0.000115	0.000278	CcSEcCtD
Risperidone—Mental disorder—Estradiol—osteoporosis	0.000115	0.000278	CcSEcCtD
Risperidone—Dizziness—Alendronate—osteoporosis	0.000114	0.000277	CcSEcCtD
Risperidone—Shock—Conjugated Estrogens—osteoporosis	0.000114	0.000277	CcSEcCtD
Risperidone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000114	0.000276	CcSEcCtD
Risperidone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000114	0.000276	CcSEcCtD
Risperidone—Malnutrition—Estradiol—osteoporosis	0.000114	0.000276	CcSEcCtD
Risperidone—Erythema—Estradiol—osteoporosis	0.000114	0.000276	CcSEcCtD
Risperidone—Fatigue—Pamidronate—osteoporosis	0.000114	0.000276	CcSEcCtD
Risperidone—Gastrointestinal pain—Risedronate—osteoporosis	0.000114	0.000275	CcSEcCtD
Risperidone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000113	0.000275	CcSEcCtD
Risperidone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000113	0.000274	CcSEcCtD
Risperidone—Pain—Pamidronate—osteoporosis	0.000113	0.000274	CcSEcCtD
Risperidone—Constipation—Pamidronate—osteoporosis	0.000113	0.000274	CcSEcCtD
Risperidone—Diarrhoea—Calcitriol—osteoporosis	0.000113	0.000273	CcSEcCtD
Risperidone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000113	0.000273	CcSEcCtD
Risperidone—Hypotension—Zoledronate—osteoporosis	0.000113	0.000273	CcSEcCtD
Risperidone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000113	0.000273	CcSEcCtD
Risperidone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000113	0.000273	CcSEcCtD
Risperidone—Dizziness—Raloxifene—osteoporosis	0.000113	0.000273	CcSEcCtD
Risperidone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000112	0.000272	CcSEcCtD
Risperidone—Flatulence—Estradiol—osteoporosis	0.000112	0.000272	CcSEcCtD
Risperidone—Tension—Estradiol—osteoporosis	0.000112	0.000271	CcSEcCtD
Risperidone—Vomiting—Estropipate—osteoporosis	0.000112	0.000271	CcSEcCtD
Risperidone—Dysgeusia—Estradiol—osteoporosis	0.000112	0.00027	CcSEcCtD
Risperidone—Dizziness—Ibandronate—osteoporosis	0.000111	0.00027	CcSEcCtD
Risperidone—Rash—Estropipate—osteoporosis	0.000111	0.000268	CcSEcCtD
Risperidone—Dermatitis—Estropipate—osteoporosis	0.000111	0.000268	CcSEcCtD
Risperidone—Anorexia—Conjugated Estrogens—osteoporosis	0.000111	0.000268	CcSEcCtD
Risperidone—Nervousness—Estradiol—osteoporosis	0.000111	0.000268	CcSEcCtD
Risperidone—Urticaria—Risedronate—osteoporosis	0.00011	0.000267	CcSEcCtD
Risperidone—Back pain—Estradiol—osteoporosis	0.00011	0.000267	CcSEcCtD
Risperidone—Headache—Estropipate—osteoporosis	0.00011	0.000267	CcSEcCtD
Risperidone—Vomiting—Alendronate—osteoporosis	0.00011	0.000267	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00011	0.000266	CcSEcCtD
Risperidone—Abdominal pain—Risedronate—osteoporosis	0.00011	0.000266	CcSEcCtD
Risperidone—Body temperature increased—Risedronate—osteoporosis	0.00011	0.000266	CcSEcCtD
Risperidone—Muscle spasms—Estradiol—osteoporosis	0.000109	0.000265	CcSEcCtD
Risperidone—Rash—Alendronate—osteoporosis	0.000109	0.000264	CcSEcCtD
Risperidone—Insomnia—Zoledronate—osteoporosis	0.000109	0.000264	CcSEcCtD
Risperidone—Dermatitis—Alendronate—osteoporosis	0.000109	0.000264	CcSEcCtD
Risperidone—Feeling abnormal—Pamidronate—osteoporosis	0.000109	0.000264	CcSEcCtD
Risperidone—Hypotension—Conjugated Estrogens—osteoporosis	0.000109	0.000263	CcSEcCtD
Risperidone—Headache—Alendronate—osteoporosis	0.000108	0.000263	CcSEcCtD
Risperidone—Paraesthesia—Zoledronate—osteoporosis	0.000108	0.000262	CcSEcCtD
Risperidone—Vomiting—Raloxifene—osteoporosis	0.000108	0.000262	CcSEcCtD
Risperidone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000108	0.000262	CcSEcCtD
Risperidone—Dyspnoea—Zoledronate—osteoporosis	0.000108	0.000261	CcSEcCtD
Risperidone—Rash—Raloxifene—osteoporosis	0.000107	0.00026	CcSEcCtD
Risperidone—Dermatitis—Raloxifene—osteoporosis	0.000107	0.00026	CcSEcCtD
Risperidone—Somnolence—Zoledronate—osteoporosis	0.000107	0.00026	CcSEcCtD
Risperidone—Vomiting—Ibandronate—osteoporosis	0.000107	0.00026	CcSEcCtD
Risperidone—Tremor—Estradiol—osteoporosis	0.000107	0.000258	CcSEcCtD
Risperidone—Headache—Raloxifene—osteoporosis	0.000107	0.000258	CcSEcCtD
Risperidone—Rash—Ibandronate—osteoporosis	0.000106	0.000257	CcSEcCtD
Risperidone—Dermatitis—Ibandronate—osteoporosis	0.000106	0.000257	CcSEcCtD
Risperidone—Dyspepsia—Zoledronate—osteoporosis	0.000106	0.000257	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000106	0.000256	CcSEcCtD
Risperidone—Ill-defined disorder—Estradiol—osteoporosis	0.000106	0.000256	CcSEcCtD
Risperidone—Headache—Ibandronate—osteoporosis	0.000106	0.000256	CcSEcCtD
Risperidone—Insomnia—Conjugated Estrogens—osteoporosis	0.000105	0.000254	CcSEcCtD
Risperidone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000105	0.000254	CcSEcCtD
Risperidone—Vomiting—Calcitriol—osteoporosis	0.000105	0.000254	CcSEcCtD
Risperidone—Decreased appetite—Zoledronate—osteoporosis	0.000105	0.000254	CcSEcCtD
Risperidone—Agitation—Estradiol—osteoporosis	0.000105	0.000254	CcSEcCtD
Risperidone—Nausea—Estropipate—osteoporosis	0.000104	0.000253	CcSEcCtD
Risperidone—Abdominal pain—Pamidronate—osteoporosis	0.000104	0.000253	CcSEcCtD
Risperidone—Body temperature increased—Pamidronate—osteoporosis	0.000104	0.000253	CcSEcCtD
Risperidone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000104	0.000253	CcSEcCtD
Risperidone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000104	0.000252	CcSEcCtD
Risperidone—Angioedema—Estradiol—osteoporosis	0.000104	0.000252	CcSEcCtD
Risperidone—Rash—Calcitriol—osteoporosis	0.000104	0.000252	CcSEcCtD
Risperidone—Fatigue—Zoledronate—osteoporosis	0.000104	0.000252	CcSEcCtD
Risperidone—Dermatitis—Calcitriol—osteoporosis	0.000104	0.000252	CcSEcCtD
Risperidone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000104	0.000251	CcSEcCtD
Risperidone—Headache—Calcitriol—osteoporosis	0.000103	0.00025	CcSEcCtD
Risperidone—Somnolence—Conjugated Estrogens—osteoporosis	0.000103	0.00025	CcSEcCtD
Risperidone—Pain—Zoledronate—osteoporosis	0.000103	0.00025	CcSEcCtD
Risperidone—Constipation—Zoledronate—osteoporosis	0.000103	0.00025	CcSEcCtD
Risperidone—Nausea—Alendronate—osteoporosis	0.000103	0.000249	CcSEcCtD
Risperidone—Malaise—Estradiol—osteoporosis	0.000103	0.000249	CcSEcCtD
Risperidone—Hypersensitivity—Risedronate—osteoporosis	0.000102	0.000248	CcSEcCtD
Risperidone—Vertigo—Estradiol—osteoporosis	0.000102	0.000248	CcSEcCtD
Risperidone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000102	0.000248	CcSEcCtD
Risperidone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000102	0.000248	CcSEcCtD
Risperidone—Syncope—Estradiol—osteoporosis	0.000102	0.000247	CcSEcCtD
Risperidone—Nausea—Raloxifene—osteoporosis	0.000101	0.000245	CcSEcCtD
Risperidone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000101	0.000245	CcSEcCtD
Risperidone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000101	0.000244	CcSEcCtD
Risperidone—Palpitations—Estradiol—osteoporosis	0.000101	0.000244	CcSEcCtD
Risperidone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.0001	0.000243	CcSEcCtD
Risperidone—Fatigue—Conjugated Estrogens—osteoporosis	0.0001	0.000243	CcSEcCtD
Risperidone—Nausea—Ibandronate—osteoporosis	0.0001	0.000243	CcSEcCtD
Risperidone—Loss of consciousness—Estradiol—osteoporosis	0.0001	0.000242	CcSEcCtD
Risperidone—Asthenia—Risedronate—osteoporosis	9.96e-05	0.000241	CcSEcCtD
Risperidone—Feeling abnormal—Zoledronate—osteoporosis	9.94e-05	0.000241	CcSEcCtD
Risperidone—Cough—Estradiol—osteoporosis	9.94e-05	0.000241	CcSEcCtD
Risperidone—Pain—Conjugated Estrogens—osteoporosis	9.93e-05	0.000241	CcSEcCtD
Risperidone—Constipation—Conjugated Estrogens—osteoporosis	9.93e-05	0.000241	CcSEcCtD
Risperidone—Gastrointestinal pain—Zoledronate—osteoporosis	9.86e-05	0.000239	CcSEcCtD
Risperidone—Hypertension—Estradiol—osteoporosis	9.83e-05	0.000238	CcSEcCtD
Risperidone—Pruritus—Risedronate—osteoporosis	9.83e-05	0.000238	CcSEcCtD
Risperidone—Nausea—Calcitriol—osteoporosis	9.8e-05	0.000237	CcSEcCtD
Risperidone—Diarrhoea—Ethinyl Estradiol—osteoporosis	9.75e-05	0.000236	CcSEcCtD
Risperidone—Hypersensitivity—Pamidronate—osteoporosis	9.73e-05	0.000236	CcSEcCtD
Risperidone—Myalgia—Estradiol—osteoporosis	9.69e-05	0.000235	CcSEcCtD
Risperidone—Chest pain—Estradiol—osteoporosis	9.69e-05	0.000235	CcSEcCtD
Risperidone—Arthralgia—Estradiol—osteoporosis	9.69e-05	0.000235	CcSEcCtD
Risperidone—Anxiety—Estradiol—osteoporosis	9.66e-05	0.000234	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	9.63e-05	0.000233	CcSEcCtD
Risperidone—Urticaria—Zoledronate—osteoporosis	9.58e-05	0.000232	CcSEcCtD
Risperidone—Discomfort—Estradiol—osteoporosis	9.58e-05	0.000232	CcSEcCtD
Risperidone—Abdominal pain—Zoledronate—osteoporosis	9.53e-05	0.000231	CcSEcCtD
Risperidone—Body temperature increased—Zoledronate—osteoporosis	9.53e-05	0.000231	CcSEcCtD
Risperidone—Diarrhoea—Risedronate—osteoporosis	9.5e-05	0.00023	CcSEcCtD
Risperidone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	9.5e-05	0.00023	CcSEcCtD
Risperidone—Dry mouth—Estradiol—osteoporosis	9.48e-05	0.00023	CcSEcCtD
Risperidone—Asthenia—Pamidronate—osteoporosis	9.47e-05	0.00023	CcSEcCtD
Risperidone—Dizziness—Ethinyl Estradiol—osteoporosis	9.42e-05	0.000228	CcSEcCtD
Risperidone—Confusional state—Estradiol—osteoporosis	9.37e-05	0.000227	CcSEcCtD
Risperidone—Pruritus—Pamidronate—osteoporosis	9.34e-05	0.000226	CcSEcCtD
Risperidone—Anaphylactic shock—Estradiol—osteoporosis	9.29e-05	0.000225	CcSEcCtD
Risperidone—Oedema—Estradiol—osteoporosis	9.29e-05	0.000225	CcSEcCtD
Risperidone—Infection—Estradiol—osteoporosis	9.23e-05	0.000224	CcSEcCtD
Risperidone—Urticaria—Conjugated Estrogens—osteoporosis	9.23e-05	0.000224	CcSEcCtD
Risperidone—Dizziness—Risedronate—osteoporosis	9.18e-05	0.000223	CcSEcCtD
Risperidone—Abdominal pain—Conjugated Estrogens—osteoporosis	9.18e-05	0.000222	CcSEcCtD
Risperidone—Body temperature increased—Conjugated Estrogens—osteoporosis	9.18e-05	0.000222	CcSEcCtD
Risperidone—Shock—Estradiol—osteoporosis	9.14e-05	0.000222	CcSEcCtD
Risperidone—Nervous system disorder—Estradiol—osteoporosis	9.11e-05	0.000221	CcSEcCtD
Risperidone—Tachycardia—Estradiol—osteoporosis	9.07e-05	0.00022	CcSEcCtD
Risperidone—Vomiting—Ethinyl Estradiol—osteoporosis	9.06e-05	0.000219	CcSEcCtD
Risperidone—Diarrhoea—Pamidronate—osteoporosis	9.03e-05	0.000219	CcSEcCtD
Risperidone—Skin disorder—Estradiol—osteoporosis	9.03e-05	0.000219	CcSEcCtD
Risperidone—Hyperhidrosis—Estradiol—osteoporosis	8.98e-05	0.000218	CcSEcCtD
Risperidone—Rash—Ethinyl Estradiol—osteoporosis	8.98e-05	0.000218	CcSEcCtD
Risperidone—Dermatitis—Ethinyl Estradiol—osteoporosis	8.97e-05	0.000217	CcSEcCtD
Risperidone—Headache—Ethinyl Estradiol—osteoporosis	8.92e-05	0.000216	CcSEcCtD
Risperidone—Hypersensitivity—Zoledronate—osteoporosis	8.89e-05	0.000215	CcSEcCtD
Risperidone—Vomiting—Risedronate—osteoporosis	8.83e-05	0.000214	CcSEcCtD
Risperidone—Rash—Risedronate—osteoporosis	8.76e-05	0.000212	CcSEcCtD
Risperidone—Dermatitis—Risedronate—osteoporosis	8.75e-05	0.000212	CcSEcCtD
Risperidone—Dizziness—Pamidronate—osteoporosis	8.73e-05	0.000212	CcSEcCtD
Risperidone—Headache—Risedronate—osteoporosis	8.7e-05	0.000211	CcSEcCtD
Risperidone—Asthenia—Zoledronate—osteoporosis	8.65e-05	0.00021	CcSEcCtD
Risperidone—Hypersensitivity—Conjugated Estrogens—osteoporosis	8.56e-05	0.000207	CcSEcCtD
Risperidone—Pruritus—Zoledronate—osteoporosis	8.53e-05	0.000207	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Estradiol—osteoporosis	8.47e-05	0.000205	CcSEcCtD
Risperidone—Nausea—Ethinyl Estradiol—osteoporosis	8.46e-05	0.000205	CcSEcCtD
Risperidone—Insomnia—Estradiol—osteoporosis	8.41e-05	0.000204	CcSEcCtD
Risperidone—Vomiting—Pamidronate—osteoporosis	8.39e-05	0.000203	CcSEcCtD
Risperidone—Paraesthesia—Estradiol—osteoporosis	8.35e-05	0.000202	CcSEcCtD
Risperidone—Asthenia—Conjugated Estrogens—osteoporosis	8.33e-05	0.000202	CcSEcCtD
Risperidone—Rash—Pamidronate—osteoporosis	8.32e-05	0.000202	CcSEcCtD
Risperidone—Dermatitis—Pamidronate—osteoporosis	8.32e-05	0.000202	CcSEcCtD
Risperidone—Dyspnoea—Estradiol—osteoporosis	8.29e-05	0.000201	CcSEcCtD
Risperidone—Headache—Pamidronate—osteoporosis	8.27e-05	0.0002	CcSEcCtD
Risperidone—Somnolence—Estradiol—osteoporosis	8.26e-05	0.0002	CcSEcCtD
Risperidone—Diarrhoea—Zoledronate—osteoporosis	8.25e-05	0.0002	CcSEcCtD
Risperidone—Nausea—Risedronate—osteoporosis	8.25e-05	0.0002	CcSEcCtD
Risperidone—Pruritus—Conjugated Estrogens—osteoporosis	8.22e-05	0.000199	CcSEcCtD
Risperidone—Dyspepsia—Estradiol—osteoporosis	8.18e-05	0.000198	CcSEcCtD
Risperidone—Decreased appetite—Estradiol—osteoporosis	8.08e-05	0.000196	CcSEcCtD
Risperidone—Gastrointestinal disorder—Estradiol—osteoporosis	8.02e-05	0.000194	CcSEcCtD
Risperidone—Fatigue—Estradiol—osteoporosis	8.01e-05	0.000194	CcSEcCtD
Risperidone—Dizziness—Zoledronate—osteoporosis	7.97e-05	0.000193	CcSEcCtD
Risperidone—Constipation—Estradiol—osteoporosis	7.95e-05	0.000193	CcSEcCtD
Risperidone—Pain—Estradiol—osteoporosis	7.95e-05	0.000193	CcSEcCtD
Risperidone—Diarrhoea—Conjugated Estrogens—osteoporosis	7.95e-05	0.000193	CcSEcCtD
Risperidone—Nausea—Pamidronate—osteoporosis	7.84e-05	0.00019	CcSEcCtD
Risperidone—Dizziness—Conjugated Estrogens—osteoporosis	7.68e-05	0.000186	CcSEcCtD
Risperidone—Vomiting—Zoledronate—osteoporosis	7.67e-05	0.000186	CcSEcCtD
Risperidone—Feeling abnormal—Estradiol—osteoporosis	7.66e-05	0.000186	CcSEcCtD
Risperidone—Rash—Zoledronate—osteoporosis	7.6e-05	0.000184	CcSEcCtD
Risperidone—Gastrointestinal pain—Estradiol—osteoporosis	7.6e-05	0.000184	CcSEcCtD
Risperidone—Dermatitis—Zoledronate—osteoporosis	7.6e-05	0.000184	CcSEcCtD
Risperidone—Headache—Zoledronate—osteoporosis	7.56e-05	0.000183	CcSEcCtD
Risperidone—Vomiting—Conjugated Estrogens—osteoporosis	7.38e-05	0.000179	CcSEcCtD
Risperidone—Urticaria—Estradiol—osteoporosis	7.38e-05	0.000179	CcSEcCtD
Risperidone—Body temperature increased—Estradiol—osteoporosis	7.35e-05	0.000178	CcSEcCtD
Risperidone—Abdominal pain—Estradiol—osteoporosis	7.35e-05	0.000178	CcSEcCtD
Risperidone—Rash—Conjugated Estrogens—osteoporosis	7.32e-05	0.000177	CcSEcCtD
Risperidone—Dermatitis—Conjugated Estrogens—osteoporosis	7.32e-05	0.000177	CcSEcCtD
Risperidone—Headache—Conjugated Estrogens—osteoporosis	7.27e-05	0.000176	CcSEcCtD
Risperidone—Nausea—Zoledronate—osteoporosis	7.16e-05	0.000174	CcSEcCtD
Risperidone—Nausea—Conjugated Estrogens—osteoporosis	6.9e-05	0.000167	CcSEcCtD
Risperidone—Hypersensitivity—Estradiol—osteoporosis	6.85e-05	0.000166	CcSEcCtD
Risperidone—Asthenia—Estradiol—osteoporosis	6.67e-05	0.000162	CcSEcCtD
Risperidone—Pruritus—Estradiol—osteoporosis	6.58e-05	0.000159	CcSEcCtD
Risperidone—Diarrhoea—Estradiol—osteoporosis	6.36e-05	0.000154	CcSEcCtD
Risperidone—Dizziness—Estradiol—osteoporosis	6.15e-05	0.000149	CcSEcCtD
Risperidone—Vomiting—Estradiol—osteoporosis	5.91e-05	0.000143	CcSEcCtD
Risperidone—Rash—Estradiol—osteoporosis	5.86e-05	0.000142	CcSEcCtD
Risperidone—Dermatitis—Estradiol—osteoporosis	5.85e-05	0.000142	CcSEcCtD
Risperidone—Headache—Estradiol—osteoporosis	5.82e-05	0.000141	CcSEcCtD
Risperidone—Nausea—Estradiol—osteoporosis	5.52e-05	0.000134	CcSEcCtD
Risperidone—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.42e-05	0.00013	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—POMC—osteoporosis	1.42e-05	0.000129	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.42e-05	0.000129	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.41e-05	0.000128	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—MTHFR—osteoporosis	1.41e-05	0.000128	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—ESR1—osteoporosis	1.39e-05	0.000127	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—LEP—osteoporosis	1.39e-05	0.000127	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.39e-05	0.000127	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.39e-05	0.000127	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.39e-05	0.000126	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.38e-05	0.000126	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	1.37e-05	0.000125	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IRS1—osteoporosis	1.36e-05	0.000124	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.36e-05	0.000124	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.35e-05	0.000123	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IRS2—osteoporosis	1.34e-05	0.000123	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.33e-05	0.000121	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IRS2—osteoporosis	1.33e-05	0.000121	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KL—osteoporosis	1.32e-05	0.000121	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.32e-05	0.000121	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SPP1—osteoporosis	1.32e-05	0.000121	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.32e-05	0.00012	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—LEP—osteoporosis	1.31e-05	0.00012	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ENO1—osteoporosis	1.31e-05	0.00012	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.31e-05	0.00012	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—POMC—osteoporosis	1.31e-05	0.00012	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—IDH2—osteoporosis	1.31e-05	0.00012	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IRS1—osteoporosis	1.3e-05	0.000119	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—POMC—osteoporosis	1.3e-05	0.000119	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.3e-05	0.000118	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—LEP—osteoporosis	1.3e-05	0.000118	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PSMA2—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PSMA5—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6R—osteoporosis	1.28e-05	0.000117	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	1.28e-05	0.000117	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.28e-05	0.000117	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—POMC—osteoporosis	1.27e-05	0.000116	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.27e-05	0.000116	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.27e-05	0.000116	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IGF1—osteoporosis	1.26e-05	0.000115	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.26e-05	0.000115	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	1.26e-05	0.000115	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—ESR1—osteoporosis	1.26e-05	0.000115	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—POMC—osteoporosis	1.25e-05	0.000114	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.25e-05	0.000114	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.24e-05	0.000113	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.24e-05	0.000113	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—ADCY5—osteoporosis	1.24e-05	0.000113	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—ESR1—osteoporosis	1.24e-05	0.000113	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ENO1—osteoporosis	1.24e-05	0.000113	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—GPX1—osteoporosis	1.24e-05	0.000113	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SPP1—osteoporosis	1.24e-05	0.000113	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.23e-05	0.000112	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.23e-05	0.000112	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6R—osteoporosis	1.22e-05	0.000112	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PSMA2—osteoporosis	1.22e-05	0.000111	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PSMA5—osteoporosis	1.22e-05	0.000111	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.22e-05	0.000111	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IGF1—osteoporosis	1.21e-05	0.00011	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ACP5—osteoporosis	1.2e-05	0.000109	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—POMC—osteoporosis	1.2e-05	0.000109	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IRS2—osteoporosis	1.2e-05	0.000109	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IRS1—osteoporosis	1.17e-05	0.000107	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.17e-05	0.000107	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.17e-05	0.000107	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.16e-05	0.000106	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—POMC—osteoporosis	1.16e-05	0.000106	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IRS1—osteoporosis	1.16e-05	0.000106	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.16e-05	0.000105	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.15e-05	0.000105	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.15e-05	0.000105	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—MTHFR—osteoporosis	1.14e-05	0.000104	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.14e-05	0.000104	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.14e-05	0.000104	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—ADCY5—osteoporosis	1.14e-05	0.000104	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GPX1—osteoporosis	1.13e-05	0.000103	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—LEP—osteoporosis	1.13e-05	0.000103	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—POMC—osteoporosis	1.13e-05	0.000103	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—LEP—osteoporosis	1.12e-05	0.000103	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—POMC—osteoporosis	1.12e-05	0.000103	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SPP1—osteoporosis	1.12e-05	0.000102	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.12e-05	0.000102	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.12e-05	0.000102	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.12e-05	0.000102	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—POMC—osteoporosis	1.11e-05	0.000102	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—TPI1—osteoporosis	1.11e-05	0.000102	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.1e-05	0.000101	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6R—osteoporosis	1.1e-05	0.000101	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SPP1—osteoporosis	1.1e-05	0.0001	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.1e-05	0.0001	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.09e-05	9.98e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6R—osteoporosis	1.09e-05	9.92e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IGF1—osteoporosis	1.09e-05	9.91e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.08e-05	9.86e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.08e-05	9.85e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.08e-05	9.82e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.07e-05	9.8e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IGF1—osteoporosis	1.07e-05	9.78e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CYP19A1—osteoporosis	1.05e-05	9.58e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—P4HB—osteoporosis	1.05e-05	9.56e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—MTHFR—osteoporosis	1.05e-05	9.54e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.04e-05	9.53e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.04e-05	9.53e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.04e-05	9.47e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GAPDH—osteoporosis	1.03e-05	9.38e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.03e-05	9.38e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IRS2—osteoporosis	1.01e-05	9.25e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.01e-05	9.2e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.01e-05	9.18e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1e-05	9.16e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IRS1—osteoporosis	1e-05	9.15e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—RAP1A—osteoporosis	1e-05	9.14e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IRS2—osteoporosis	9.98e-06	9.11e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IRS2—osteoporosis	9.96e-06	9.09e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—LEP—osteoporosis	9.93e-06	9.06e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.9e-06	9.03e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6R—osteoporosis	9.81e-06	8.95e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IRS2—osteoporosis	9.77e-06	8.92e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—LEP—osteoporosis	9.77e-06	8.91e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IRS1—osteoporosis	9.76e-06	8.9e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—LEP—osteoporosis	9.75e-06	8.89e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—POMC—osteoporosis	9.71e-06	8.86e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IGF1—osteoporosis	9.68e-06	8.83e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—POMC—osteoporosis	9.66e-06	8.82e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—IL6—osteoporosis	9.64e-06	8.8e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IRS1—osteoporosis	9.6e-06	8.76e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—IL6—osteoporosis	9.58e-06	8.74e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—LEP—osteoporosis	9.56e-06	8.73e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ESR1—osteoporosis	9.48e-06	8.65e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6R—osteoporosis	9.47e-06	8.64e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6R—osteoporosis	9.42e-06	8.6e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—POMC—osteoporosis	9.4e-06	8.57e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—IL6—osteoporosis	9.38e-06	8.56e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IGF1—osteoporosis	9.34e-06	8.52e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ESR1—osteoporosis	9.32e-06	8.51e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ESR1—osteoporosis	9.3e-06	8.49e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IGF1—osteoporosis	9.29e-06	8.48e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—POMC—osteoporosis	9.25e-06	8.44e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—IL6—osteoporosis	9.23e-06	8.42e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6R—osteoporosis	9.17e-06	8.36e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ESR1—osteoporosis	9.13e-06	8.33e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—POMC—osteoporosis	9.13e-06	8.33e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IRS2—osteoporosis	9.08e-06	8.28e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IGF1—osteoporosis	9.04e-06	8.25e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6R—osteoporosis	9.02e-06	8.23e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IGF1—osteoporosis	8.9e-06	8.12e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—LEP—osteoporosis	8.88e-06	8.11e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IRS1—osteoporosis	8.85e-06	8.08e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—IL6—osteoporosis	8.81e-06	8.04e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IRS1—osteoporosis	8.71e-06	7.95e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IRS1—osteoporosis	8.69e-06	7.93e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ADCY5—osteoporosis	8.58e-06	7.83e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GPX1—osteoporosis	8.55e-06	7.8e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IRS1—osteoporosis	8.53e-06	7.78e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—POMC—osteoporosis	8.53e-06	7.78e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ESR1—osteoporosis	8.48e-06	7.74e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—POMC—osteoporosis	8.39e-06	7.66e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—POMC—osteoporosis	8.37e-06	7.64e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—POMC—osteoporosis	8.36e-06	7.63e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6R—osteoporosis	8.32e-06	7.59e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—IL6—osteoporosis	8.31e-06	7.58e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—POMC—osteoporosis	8.21e-06	7.5e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IGF1—osteoporosis	8.2e-06	7.48e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—IL6—osteoporosis	8.2e-06	7.48e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6R—osteoporosis	8.18e-06	7.47e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6R—osteoporosis	8.17e-06	7.45e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ENO1—osteoporosis	8.09e-06	7.39e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ADCY5—osteoporosis	8.09e-06	7.38e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IGF1—osteoporosis	8.07e-06	7.36e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GPX1—osteoporosis	8.06e-06	7.35e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IGF1—osteoporosis	8.05e-06	7.35e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6R—osteoporosis	8.01e-06	7.31e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PSMA2—osteoporosis	7.98e-06	7.28e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PSMA5—osteoporosis	7.98e-06	7.28e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IRS1—osteoporosis	7.93e-06	7.23e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IGF1—osteoporosis	7.9e-06	7.21e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—MTHFR—osteoporosis	7.89e-06	7.2e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—POMC—osteoporosis	7.63e-06	6.96e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MYC—osteoporosis	7.58e-06	6.91e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TGFB1—osteoporosis	7.56e-06	6.9e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MYC—osteoporosis	7.53e-06	6.87e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TGFB1—osteoporosis	7.51e-06	6.85e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6R—osteoporosis	7.45e-06	6.79e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MTHFR—osteoporosis	7.44e-06	6.79e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—IL6—osteoporosis	7.4e-06	6.75e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MYC—osteoporosis	7.37e-06	6.72e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TGFB1—osteoporosis	7.35e-06	6.71e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IGF1—osteoporosis	7.34e-06	6.7e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MYC—osteoporosis	7.25e-06	6.62e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TGFB1—osteoporosis	7.23e-06	6.6e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL6—osteoporosis	7.14e-06	6.52e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL6—osteoporosis	7.11e-06	6.48e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MYC—osteoporosis	6.92e-06	6.32e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL6—osteoporosis	6.91e-06	6.31e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFB1—osteoporosis	6.91e-06	6.3e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL6—osteoporosis	6.8e-06	6.21e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MYC—osteoporosis	6.53e-06	5.96e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFB1—osteoporosis	6.51e-06	5.94e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.47e-06	5.9e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MYC—osteoporosis	6.44e-06	5.88e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFB1—osteoporosis	6.43e-06	5.86e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—POMC—osteoporosis	6.31e-06	5.76e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—osteoporosis	6.27e-06	5.72e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—osteoporosis	6.17e-06	5.63e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—osteoporosis	6.16e-06	5.62e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—osteoporosis	6.04e-06	5.51e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—POMC—osteoporosis	5.95e-06	5.43e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—osteoporosis	5.82e-06	5.31e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	5.8e-06	5.29e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—osteoporosis	5.69e-06	5.2e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—osteoporosis	5.66e-06	5.16e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—osteoporosis	5.61e-06	5.12e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—osteoporosis	5.61e-06	5.12e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.6e-06	5.11e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—osteoporosis	5.58e-06	5.1e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—osteoporosis	5.57e-06	5.08e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—osteoporosis	5.54e-06	5.05e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—osteoporosis	5.45e-06	4.97e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—osteoporosis	5.43e-06	4.96e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	5.42e-06	4.94e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—osteoporosis	5.35e-06	4.88e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	5.33e-06	4.87e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ADCY5—osteoporosis	5.29e-06	4.82e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GPX1—osteoporosis	5.27e-06	4.81e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—osteoporosis	5.2e-06	4.75e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—osteoporosis	4.93e-06	4.5e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.92e-06	4.49e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—osteoporosis	4.91e-06	4.48e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MTHFR—osteoporosis	4.86e-06	4.44e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—osteoporosis	4.85e-06	4.43e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—osteoporosis	4.84e-06	4.42e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—osteoporosis	4.84e-06	4.42e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.84e-06	4.41e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.83e-06	4.4e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—osteoporosis	4.75e-06	4.33e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	4.74e-06	4.32e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—osteoporosis	4.41e-06	4.03e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	4.4e-06	4.02e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—osteoporosis	4.37e-06	3.99e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—osteoporosis	4.22e-06	3.85e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—osteoporosis	4.2e-06	3.83e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—osteoporosis	4.08e-06	3.73e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—osteoporosis	4.02e-06	3.67e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—POMC—osteoporosis	3.89e-06	3.55e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—osteoporosis	3.71e-06	3.38e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—osteoporosis	3.65e-06	3.33e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—osteoporosis	3.64e-06	3.32e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—osteoporosis	3.57e-06	3.26e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—osteoporosis	3.32e-06	3.03e-05	CbGpPWpGaD
